Lilly eczema trials open doors to new treatment hope

Eczema

Eczema remains one of the most common chronic skin conditions, yet its impact is not evenly distributed. For many African American patients, the condition presents differently, lasts longer, and is often underdiagnosed or mismanaged. New clinical research, including trials backed by Eli Lilly and Company, is beginning to address these gaps while expanding access to […]

Eczema has 4 findings that explain why the rash is never really just a skin problem

Eczema

Eczema is the condition that most people who have it manage with a combination of moisturizers, avoidance strategies, and the particular resignation that comes from having tried many things that worked partially and briefly before the skin decided it had other plans. The cultural understanding of this condition as a skin problem, while technically accurate […]